Publications
Transposition of the great arteries in a neonate with Klinefelter syndrome-an incidental finding or a true association. Liu, J., Moulick, A., Mesia, C. I., Ge, S., Obiri, N.,Anderson, C. E.; Am. J. Med. Genet. A. 2014 Oct 24. Structure of and signal transduction through interleukin-4 and interleukin-13 receptors (review).Murata, T., Obiri, N. I., Puri, R. K.; Int J Mol Med. 1998 Mar.
Receptor for interleukin 13 on AIDS-associated Kaposi's sarcoma cells serves as a new target for a potent Pseudomonas exotoxin-based chimeric toxin protein. Husain, S. R., Obiri, N. I., Gill, P., Zheng, T., Pastan, I., Debinski, W., Puri, R. K.; Clin Cancer Res. 1997 Feb.
Novel anti-brain tumor cytotoxins specific for cancer cells. Debinski, W., Gibo, D. M., Obiri, N. I., Kealiher, A., Puri, R. K.; Nat Biotechnol. 1998 May.
Structure of IL-13 receptor: analysis of subunit composition in cancer and immune cells. Murata, T., Obiri, N. I., Debinski, W., Puri, R. K.; Biochem Biophys Res Commun. 1997 Sep 8.
Modulation of interleukin (IL)-13 binding and signaling by the gammac chain of the IL-2 receptor. Obiri, N. I., Murata, T., Debinski, W., Puri, R. K.; J Biol Chem. 1997 Aug 8.
Human ovarian-carcinoma cell lines express IL-4 and IL-13 receptors: comparison between IL-4- and IL-13-induced signal transduction. Murata, T., Obiri, N. I., Puri, R. K.; Int J Cancer. 1997 Jan 17.
The IL-13 receptor structure differs on various cell types and may share more than one component with IL-4 receptor. Obiri, N. I., Leland, P., Murata, T., Debinski, W., Puri, R. K.; J Immunol. 1997 Jan 15.
Patient Comments